Scynexis (SCYX) Net Cash Flow (2013 - 2026)
Scynexis' (SCYX) quarterly Net Cash Flow came in at $15.4 million in Q1 2026, up 269.2% YoY from $4.2 million in Q1 2025, and up 138.5% on a QoQ basis from $6.5 million in Q4 2025.
Scynexis (SCYX) Net Cash Flow (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Net Cash Flow data on file, last reported at $15.4 million in Q1 2026.
- Quarterly Net Cash Flow rose 269.2% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.4 million (up 202.93% YoY) and the FY2025 annual result came in at $4.9 million, up 126.96% from the prior year.
- Net Cash Flow grew to $15.4 million in Q1 2026, from $6.5 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $31.4 million in Q2 2023 to a low of -$50.1 million in Q3 2022.
- A 5-year average of -$4.0 million and a median of -$9.1 million in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 800.39% — and 2026, when it jumped 269.2%.
- Tracing SCYX's Net Cash Flow over 5 years: stood at -$22.8 million in 2022, then jumped by 56.06% to -$10.0 million in 2023, then retreated by 26.51% to -$12.7 million in 2024, then soared by 150.97% to $6.5 million in 2025, then jumped by 138.5% to $15.4 million in 2026.
- The last three Net Cash Flow figures came in at $15.4 million (Q1 2026), $6.5 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | -26.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.18 Mn |
| Jun 30, 2026 | -26.18 Mn |
| Mar 31, 2026 | 15.41 Mn |
| Mar 31, 2026 | 15.41 Mn |
| Dec 31, 2025 | 6.46 Mn |
| Dec 31, 2025 | 6.46 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | -9.11 Mn |
| Mar 31, 2025 | -9.11 Mn |
| Dec 31, 2024 | -12.68 Mn |
| Dec 31, 2024 | -12.68 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | -9.49 Mn |
| Jun 30, 2024 | -9.49 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.43 Mn |